menu
    • menu

    Company profile for SanBio

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Established in February 2001, SanBio is dedicated to the development, manufacturing, and marketing of regenerative cell therapies. Our objective is to advance regenerative medicines, bringing advantages to patients and generating value for stakeholders. We aspire to attain worldwide leadership in the regenerative medicine sector by leveraging cutting-edge science and technology, expanding global revenues, and supporting succes...
    Established in February 2001, SanBio is dedicated to the development, manufacturing, and marketing of regenerative cell therapies. Our objective is to advance regenerative medicines, bringing advantages to patients and generating value for stakeholders. We aspire to attain worldwide leadership in the regenerative medicine sector by leveraging cutting-edge science and technology, expanding global revenues, and supporting successful clinical trials. SanBio's primary focus lies in employing regenerative cell therapies to address disabilities resulting from central nervous system disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SanBiojapan Flag
    Country
    Country
    Japan
    Address
    Address
    8-1 Akashi-cho, Chuo-ku, Tokyo, 104-0044
    Telephone
    Telephone
    +81 362643481
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sanbio.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sanbiobiotech/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SB623 Demonstrated Sustained Improvement in Motor Impairment up to 48 Weeks
    SB623 Demonstrated Sustained Improvement in Motor Impairment up to 48 Weeks

    05 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220404006059/en

    BUSINESSWIRE
    05 Apr 2022
    Share Share
    SanBio: Notice Regarding Completion of Approval Filing for Japan SB623
    SanBio: Notice Regarding Completion of Approval Filing for Japan SB623

    07 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220306005091/en

    BUSINESSWIRE
    07 Mar 2022
    Share Share
    SanBio Announces Publication Comparing Outcome Measures
    SanBio Announces Publication Comparing Outcome Measures

    01 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211101005388/en/SanBio-Announces-Publication-Comparing-Outcome-Measures-for-Persons-With-Chronic-Traumatic-Brain-Injury-in-Expert-Review-of-Neurotherapeutics

    BUSINESSWIRE
    01 Nov 2021
    Share Share
    SanBio Announces Publication of STEMTRA Phase 2 Interim Analysis for SB623
    SanBio Announces Publication of STEMTRA Phase 2 Interim Analysis for SB623

    04 Jan 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210104005858/en

    BUSINESSWIRE
    04 Jan 2021
    Share Share
    Additional Analytical Results of the Phase 2 Trial of Regenerative Cell Medicine
    Additional Analytical Results of the Phase 2 Trial of Regenerative Cell Medicine

    13 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200913005076/en

    BUSINESSWIRE
    13 Sep 2020
    Share Share
    SanBio to Announce the Results of a Phase 2 STEMTRA Tria SB623
    SanBio to Announce the Results of a Phase 2 STEMTRA Tria SB623

    07 Mar 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190306005896/en/SanBio-Announce-Results-Phase-2-STEMTRA-Trial/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

    BUSINESSWIRE
    07 Mar 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search